Table 3.
Summary of data collection and data analysis approaches.
|
|
Type and setup of device | Follow-up | Other outcome measures | Data analysis | ||||||
| Study | Body location | Device (type and name) | Sampling frequency (Hz) | Duration of follow-up | Duration and frequency of measurements | Outcome measures | Epochs used in analysis (s) | |||
| van Eijk et al [24] | Right hip (anterior axillary line) | Triaxial accelerometer ActiGraph GT9XLink | 30 | 18 mo | 7 consecutive d every 2-3 mo | ALSFRS-Ra, Hospital Anxiety and Depression Scale, weight, wear time log | 10 | |||
| Garcia-Gancedo et al [20] | Chest | Triaxial accelerometer Mega faros 180 | 50 | 48 wk | 3 consecutive d every mo | ALSFRS-R, forced vital capacity, heart rate variability, speech | 60 | |||
| Kelly et al [22] | Chest | Triaxial accelerometer; Mega Faros 180 | 50 | 48 wk | 3 consecutive d every mo | ALSFRS-R, forced vital capacity, heart rate variability, speech | 60 (based on information from Garcia-Gancedo et al. [20]) | |||
| Rutkove et al [21] | Not stated Device designed for wrist | Mi Band R | Not reported | 9 mo | Daily for 90 d, then biweekly for 180 d | ALSFRS-R, speech, electrical impedance myography tool, respiratory data, muscle strength, patient-reported experience measures | Not relevant | |||
| Rutkove et al [23] | Not stated Device designed for wrist | Mi Band R | Not reported | 9 mo | Daily for 90 d, then biweekly for 180 d | ALSFRS-R, speech, electrical impedance myography tool, respiratory data, muscle strength, patient-reported experience measures | Not relevant | |||
| Karas et al [25] | Not relevant | Personal phone (triaxial accelerometer and GPS) | 10 (accelerometer) | Up to 1 y | Continuous cyclical accelerometer 10 s on or off GPS 1 min on or 10 min off | ALSFRS-RSEb | 60 | |||
| Holdom et al [26] | Wrist (nondominant), right hip | Triaxial accelerometer ActiGraph GT9XLink | 30 | 18 mo | Wrist—8 consecutive d every 3-4 months and hip—7 consecutive d every 2-3 mo | ALSFRS-R | 10 | |||
| Johnson et al [27] | Wrist or ankle | Wrist: triaxial accelerometer ActiGraph Insight Watch, Ankle: biaxial accelerometer Modus StepWatch 4 | Wrist: 32 and ankle: 128 | 6 mo | As much as possible for the duration of the study | ALSFRS-R, ALSFRS-RSE, Rasch-Built Overall ALSc Disability Scale | 60 | |||
| Gupta et al. [28] | All 4 limbs (wrists and ankles) | Triaxial accelerometer ActiGraph GT3X | 30 | Minimum of 0.75 y stated | 7 d every mo | ALSFRS-R | 1 | |||
| van Unnik et al [29] | Right hip (anteroaxillary line) | Triaxial accelerometer ActiGraph GT9XLink | 30 | 18-24 mo | 3-7 d every 2-3 mo | Survival status, ALSFRS-R (self-administered or physician administered) | 10 | |||
| Beswick et al [30] | Right wrist and Right ankle | Triaxial accelerometer ActiGraph GT9X | Not disclosed | 12 wk | 24 h every 2 wk | ALSFRS-R, 6-minute walking test, questionnaires to provide feedback on their experience of wearing devices, standardized series of movements | Not disclosed | |||
| Straczkiewicz et al [31] | Wrist of choice | Triaxial accelerometer ActiGraph, Insight Watch | 32 | 6 mo | Continuously, except for recharging (required every few weeks) | ALSFRS-RSE | 60 (for total activity counts) | |||
aALSFRS-R: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised.
bALSFRS-RSE: Amyotrophic Lateral Sclerosis Functional Rating Scale self-administered.
cALS: amyotrophic lateral sclerosis.